OBJECTIVE: To determine the features predictive of atherosclerotic cardiovascular damage in patients with SLE. METHODS: SLE LUMINA (LUpus in MInorities: NAture vs nurture) patients (n = 637), aged >or=16 years, disease duration <or=5 years at baseline (T0), of African-American, Hispanic and Caucasian ethnicity were studied. Atherosclerotic cardiovascular damage was defined by the following items of the SLICC Damage Index (SDI) cardiovascular domain: angina or coronary artery by pass surgery, myocardial infarction and/or congestive heart failure; factors associated with its occurrence were examined by univariable and multivariable regression analyses. RESULTS: Forty-three (6.8%) of 637 patients developed cardiovascular damage over a mean +/- S.D. total disease duration of 6.6 +/- 3.6 years. Nearly 90% of the patients were women with a mean +/- s.d. age of 36.5 (12.6) years; all ethnic groups were represented. By multivariable analyses, after adjusting for the cardiovascular manifestations present, age [odds ratio (OR) = 1.06; 95% CI 1.03, 1.09], male gender (OR = 3.57; 95% CI 1.35, 9.09) SDI at baseline (OR = 1.28; 95% CI 1.09, 1.50) and CRP levels [highest tertile (OR = 2.63; 95% CI 1.17, 5.91)] were associated with the occurrence of cardiovascular damage, whereas the number of years of education was negatively associated with such outcome (OR = 0.85; 95% CI 0.74, 0.94). CONCLUSIONS: Our data suggest that atherosclerotic cardiovascular damage in SLE is multifactorial; traditional (age, gender) and disease-related factors (CRP levels, SDI at baseline) appear to be important contributors to such an occurrence. Tight control of the inflammatory process must be achieved to prevent it.
OBJECTIVE: To determine the features predictive of atherosclerotic cardiovascular damage in patients with SLE. METHODS:SLE LUMINA (LUpus in MInorities: NAture vs nurture) patients (n = 637), aged >or=16 years, disease duration <or=5 years at baseline (T0), of African-American, Hispanic and Caucasian ethnicity were studied. Atherosclerotic cardiovascular damage was defined by the following items of the SLICC Damage Index (SDI) cardiovascular domain: angina or coronary artery by pass surgery, myocardial infarction and/or congestive heart failure; factors associated with its occurrence were examined by univariable and multivariable regression analyses. RESULTS: Forty-three (6.8%) of 637 patients developed cardiovascular damage over a mean +/- S.D. total disease duration of 6.6 +/- 3.6 years. Nearly 90% of the patients were women with a mean +/- s.d. age of 36.5 (12.6) years; all ethnic groups were represented. By multivariable analyses, after adjusting for the cardiovascular manifestations present, age [odds ratio (OR) = 1.06; 95% CI 1.03, 1.09], male gender (OR = 3.57; 95% CI 1.35, 9.09) SDI at baseline (OR = 1.28; 95% CI 1.09, 1.50) and CRP levels [highest tertile (OR = 2.63; 95% CI 1.17, 5.91)] were associated with the occurrence of cardiovascular damage, whereas the number of years of education was negatively associated with such outcome (OR = 0.85; 95% CI 0.74, 0.94). CONCLUSIONS: Our data suggest that atherosclerotic cardiovascular damage in SLE is multifactorial; traditional (age, gender) and disease-related factors (CRP levels, SDI at baseline) appear to be important contributors to such an occurrence. Tight control of the inflammatory process must be achieved to prevent it.
Authors: J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal Journal: Arthritis Rheum Date: 2001-10
Authors: S Rosner; E M Ginzler; H S Diamond; M Weiner; M Schlesinger; J F Fries; C Wasner; T A Medsger; G Ziegler; J H Klippel; N M Hadler; D A Albert; E V Hess; G Spencer-Green; A Grayzel; D Worth; B H Hahn; E V Barnett Journal: Arthritis Rheum Date: 1982-06
Authors: Yu Asanuma; Annette Oeser; Ayumi K Shintani; Elizabeth Turner; Nancy Olsen; Sergio Fazio; MacRae F Linton; Paolo Raggi; C Michael Stein Journal: N Engl J Med Date: 2003-12-18 Impact factor: 91.245
Authors: Haim D Danenberg; Alexander J Szalai; Rajesh V Swaminathan; Lin Peng; Zhiping Chen; Philip Seifert; William P Fay; Daniel I Simon; Elazer R Edelman Journal: Circulation Date: 2003-07-21 Impact factor: 29.690
Authors: Antoni Paul; Kerry W S Ko; Lan Li; Vijay Yechoor; Mark A McCrory; Alexander J Szalai; Lawrence Chan Journal: Circulation Date: 2004-01-26 Impact factor: 29.690
Authors: Sarah K Chen; Medha Barbhaiya; Michael A Fischer; Hongshu Guan; Kazuki Yoshida; Candace H Feldman; Karen H Costenbader; Brendan M Everett Journal: Semin Arthritis Rheum Date: 2019-06-11 Impact factor: 5.532
Authors: Vaneet K Sandhu; Janet Wei; Louise E J Thomson; Daniel S Berman; Jay Schapira; Daniel Wallace; Michael H Weisman; C Noel Bairey Merz; Mariko L Ishimori Journal: Arthritis Care Res (Hoboken) Date: 2020-06-04 Impact factor: 4.794
Authors: Wojciech Plazak; Mieczyslaw Pasowicz; Magdalena Kostkiewicz; Jakub Podolec; Lidia Tomkiewicz-Pajak; Jacek Musial; Piotr Podolec Journal: Inflamm Res Date: 2011-07-10 Impact factor: 4.575
Authors: Wojciech Plazak; Krzysztof Gryga; Hanna Dziedzic; Lidia Tomkiewicz-Pajak; Malgorzata Konieczynska; Piotr Podolec; Jacek Musial Journal: Arthritis Res Ther Date: 2011-07-20 Impact factor: 5.156
Authors: May Y Choi; Daniel Li; Candace H Feldman; Kazuki Yoshida; Hongshu Guan; Seoyoung C Kim; Brendan M Everett; Karen H Costenbader Journal: Rheumatology (Oxford) Date: 2021-08-02 Impact factor: 7.580